Literature DB >> 14627461

The validation of the Moorehead-Ardelt Quality of Life Questionnaire II.

Melodie K Moorehead1, Elisabeth Ardelt-Gattinger, Hans Lechner, Horacio E Oria.   

Abstract

BACKGROUND: The Moorehead-Ardelt Quality of Life Questionnaire was originally developed as a disease-specific instrument to measure postoperative outcomes of self-perceived quality of life (QoL) in obese patients. 5 key areas were examined: self-esteem, physical well-being, social relationships, work, and sexuality. Each of these questions offered 5 possible answers, which were given + or - points according to a scoring key. The questionnaire was used independently or incorporated into the Bariatric Analysis and Reporting System (BAROS). The instrument is simple, unbiased, user-friendly and can be completed in <1 minute. It has been found useful, reliable and reproducible in numerous clinical trials in different countries. Further research and feedback from some of its users prompted refinements, now included in the Moorehead-Ardelt Quality of Life Questionnaire II (M-A QoLQII). This study tested the validity of the improved instrument.
METHODS: The wording of the questions was changed, to make them less suggestive and allow for the use of the survey before and after medical intervention, and with control groups. A 6th question, analyzing eating behavior, was added. The +/-1 point given to the evaluation of self-esteem was split with this new question, thus maintaining the consistency of the scores. The drawings were simplified. Finally, the scoring key was changed to a 10-point Likert scale, to improve response-differentiation. To validate the M-A QoLQII, we examined its concordance with other health and well-being indicators, specifically the MOS 36-Item Short-Form Health Survey (SF-36), the Beck Depression Inventory-II (BDI-II) and the Stunkard and Messick Eating Inventory. The study population included 110 morbidly obese patients (20 males, 90 females, mean BMI=50), participants of gastric bypass support groups. Reliability of the M-A QoLQII was determined using Cronbach's alpha coefficient. Construct validity was measured by conducting a series of Spearman rank correlations.
RESULTS: A Cronbach's alpha coefficient of 0.84 indicated satisfactory internal consistency. The M-A QoLQII was found to be significantly correlated (P <0.01) to 7 of the 8 SF-36 scales: Physical Role (r=0.357), Bodily Pain (r=-0.486), General Health (r=0.413), Vitality (r=0.588), Social Functioning (r=0.517), Emotional Role (r=0.480), and Mental Health (r=0.489). The questionnaire also significantly correlated (P <0.01) to the Beck Depression Inventory-II (r=0.317), as well as to the 'Disinhibition' (r=-0.307) and 'Hunger' (r=-0.254) factors of the Stunkard and Messick Eating Inventory.
CONCLUSIONS: The M-A QoLQII correlates well with other widely used health and well-being indicators such as the SF-36, Beck Depression Inventory II and the Stunkard and Messick Eating Inventory. The study established the validity and reliability of this improved disease-specific instrument for QoL measurement in the obese population.

Entities:  

Mesh:

Year:  2003        PMID: 14627461     DOI: 10.1381/096089203322509237

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  85 in total

1.  Willingness to pay as patient preference to bariatric surgery.

Authors:  Cristina Khawali; Marcos B Ferraz; Maria T Zanella; Sandra R G Ferreira
Journal:  Health Expect       Date:  2011-11-10       Impact factor: 3.377

2.  Long-term results of biliopancreatic diversion with or without gastric preservation for morbid obesity.

Authors:  Nicola Crea; Giacomo Pata; Ernesto Di Betta; Francesco Greco; Claudio Casella; Antonio Vilardi; Francesco Mittempergher
Journal:  Obes Surg       Date:  2011-02       Impact factor: 4.129

3.  Assessing quality of life in severe obesity: development and psychometric properties of the ORWELL-R.

Authors:  José Camolas; André Ferreira; Edoardo Mannucci; Mário Mascarenhas; Manuel Carvalho; Pedro Moreira; Isabel do Carmo; Osvaldo Santos
Journal:  Eat Weight Disord       Date:  2015-10-01       Impact factor: 4.652

4.  Long-Term Outcomes After One-Anastomosis Gastric Bypass (OAGB) in Morbidly Obese Patients.

Authors:  Maud Neuberg; Marie-Cécile Blanchet; Benoit Gignoux; Vincent Frering
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

5.  Patient Perspective in Obesity Surgery: Goals for Weight Loss and Improvement of Body Shape in a Prospective Cohort Study.

Authors:  Felix Nickel; Lukas Schmidt; Johannes Sander; Christian Tapking; Thomas Bruckner; Beat-Peter Müller-Stich; Lars Fischer
Journal:  Obes Facts       Date:  2018-12-11       Impact factor: 3.942

6.  Do Male Patients Benefit from Laparoscopic Adjustable Gastric Banding More than Female Patients? A Retrospective Cohort Study.

Authors:  Maor Lewis; Uri Netz; Solly Mizrahi; Eliezer Avinoah; Doron Gal; Zvi H Perry
Journal:  Obes Surg       Date:  2018-03       Impact factor: 4.129

7.  Translation, adaptation and validation of a Portuguese version of the Moorehead-Ardelt Quality of Life Questionnaire II.

Authors:  João Maciel; Paulo Infante; Susana Ribeiro; André Ferreira; Artur C Silva; Jorge Caravana; Manuel G Carvalho
Journal:  Obes Surg       Date:  2014-11       Impact factor: 4.129

8.  Quality of life in morbidly obese patients after surgical weight loss.

Authors:  Johann F Kinzl; Maria Schrattenecker; Christian Traweger; Franz Aigner; Michaela Fiala; Wilfried Biebl
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

9.  Two-year results on morbidity, weight loss and quality of life of sleeve gastrectomy as first procedure, sleeve gastrectomy after failure of gastric banding and gastric banding.

Authors:  Charles Sabbagh; Pierre Verhaeghe; Abdennaceur Dhahri; Olivier Brehant; David Fuks; Rachid Badaoui; Jean-Marc Regimbeau
Journal:  Obes Surg       Date:  2009-11-10       Impact factor: 4.129

Review 10.  Quality of Life Outcomes of Bariatric Surgery: A Systematic Review.

Authors:  Aleeya Hachem; Leah Brennan
Journal:  Obes Surg       Date:  2016-02       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.